Diabesity - novel molecular targets for obesity and type 2 diabetes
 
Diabesity: Novel molecular targets for obesity and type 2 diabetes
Members
The DIABESITY project involved 27 partners in 24 European institutions.

However the project is now terminated.Final Report and contact details

The Karolinska Institute The University of Göteborg The Royal Veterinary & Agricultural University German Institute of Human Nutrition The University of Cologne DeveloGen AG University of Duisburg Essen European Molecular Biology Laboratory Ingenium Pharmaceuticals University of Geneva University of Turin The University of Bologna The Hungarian Academy of Sciences IntegraGen SA Institut Pasteur de Lille Centre National de la Recherche Scientifique The University of Cambridge Imperial College London MRC Mammalian Genetics Genome Research Limited The University of Edinburgh The Rowett Research Institute Trinity College Dublin University of Sandiago de Compostella

   
The University of Göteborg, Sweden   Prof Suzanne Dickson
Göteborg University, Sweden
       
The University of Göteborg, Sweden  

Prof Sven Enerbäck
Göteborg University, Sweden

       
The University of Göteborg, Sweden  

Prof John-Olov Jansson
Göteborg University, Sweden

     
The Royal Veterinary & Agricultural University, Denmark  

Prof Arne Vernon Astrup
The Royal Veterinary & Agricultural University, Denmark

     
     
Genome Research Limited, UK   Dr Inês Barroso
Genome Research Limited, UK
     
     
Imperial College London, UK   Prof Steve Bloom
Imperial College London, UK
     
     
DeveloGen AG, Germany   Dr Marcus Geese
DeveloGen AG, Germany
     
     
The University of Cologne, Germany   Prof Jens Bruning
The University of Cologne, Germany
     
MRC Mammalian Genetics Unit, UK   Dr Roger Cox
MRC Mammalian Genetics Unit, UK
     
     
The University of Sandiago de Compostella, Spain   Prof Carlos Dieguez
The University of Sandiago de Compostella, Spain
     
     
The University of Turin, Italy   Prof Ezio Ghigo
The University of Turin, Italy
     
Ingenium Pharmaceuticals AG, Germany   Dr Heike Schauerte
Ingenium Pharmaceuticals AG, Germany
     
     
IntegraGen SA, France   Dr Jorg Hager
IntegraGen SA, France
     
     
The University of Duisberg-Essen, Germany   Prof Johannes Hebebrand
The University of Duisberg-Essen, Germany
     
     
The University of Edinburgh, UK   Prof Gareth Leng
The University of Edinburgh, UK
       
The University of Edinburgh, UK   Prof Jonathan Seckl
The University of Edinburgh, UK

     
The Hungarian Academy of Sciences, Hungary   Prof Zsolt Liposits
The Hungarian Academy of Sciences, Hungary
     
     
The Karolinska Institute, Sweden   Prof Bjorn Meister
The Karolinska Institute, Sweden
     
     
The Rowett Research Institute, UK   Dr Julian Mercer
The Rowett Research Institute, UK
     
     
Trinity College Dublin, Ireland   Prof John Nolan
Trinity College Dublin, Ireland
     
The University of Cambridge, UK   Prof Steve O'Rahilly
The University of Cambridge, UK
     
     
The University of Bologna, Italy   Dr Uberto Pagotto
The University of Bologna, Italy
     
     
Centre National de la Recherche Scientifique, France   Prof Daniel Ricquier
Centre National de la Recherche Scientifique, France
     
     
University of Geneva, Switzerland   Dr Francois Rohner-Jeanrenaud
University of Geneva, Switzerland
     
     
Institut Pasteur de Lille, France   Prof Bart Staels
Institut Pasteur de Lille, France
     
     
European Molecular Biology Laboratory, Germany   Dr Mathias Treier
European Molecular Biology Laboratory, Germany
     
German Institute of Human Nutrition, Germany   Prof Matthias Tschöp
German Institute of Human Nutrition, Germany
     
       

 

   
  home | research | publications | members | events | about diabesity | press | links | contact us